Work

Neo-antigen tumor vaccination depends on CD4-licensing conveyed by adeno-associated virus like particles

Year: 2025

Type: article

Abstract: T cell responses and suggest a future use of AAVLPs as neo-epitope vaccines in personalized cancer treatments.

Source: Molecular Therapy

DOI: 10.1016/j.ymthe.2025.07.014

Authors: Lasse Neukirch, Silke Uhrig-Schmidt, Katharina von Werthern, Alexandra Tuch, Joscha A. Kraske, Yanhong Lyu, Benedicte Lenoir, Stefan B. Eichmüller, Marten Meyer, Inka Zörnig, Dirk Jäger, Patrick Schmidt

Institutions: German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,500

OpenAlex ID: W4412468112

FWCI: 0.911

Cites: 39

Cited by: 3

Related to: 10